Abstract
A thiazine derivative of AzB, the monoiodinated Azure B (AzBI), was designed, characterized, chemical and photochemically evaluated, and screened for antibacterial activity.The monoiodinated derivative showed better chemical and photochemical properties compared to the leading compound Azure B (AzB). Also, AzBI exhibited good antibacterial activity against methicillin-sensitive Staphylococcus aureus (MSSA) ATCC 29213 and methicillin-resistant S. aureus (MRSA) ATCC 43300. The assayed compound represents a promising structure for the development of a new synthetic photosensitizer with improved properties and biological activity.Based on the results obtained for AzBI, this compound was loaded in the polymeric nanoparticles synthesized by our working group in order to improve some of its physicochemical properties. In this way, it was possible to successfully load the monoiodinated derivative and yield a promising drug transport system. The latter presented better characteristics and antimicrobial activity than AzBI against the different strains tested. All these results make AzBI an excellent candidate for application in photodynamic therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
